XHKG
3390
Market cap28mUSD
Oct 09, Last price
0.25HKD
1D
0.81%
1Q
6.38%
IPO
-75.00%
Name
Tycoon Group Holdings Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Tycoon Group Holdings Limited functions as an investment holding enterprise, specializing in the worldwide distribution and retail of an extensive portfolio of health and wellness products. Its market presence extends across Hong Kong, Mainland China, Macau, and various international regions. The company's operations are divided into three distinct divisions: Distribution, E-Commerce, and physical Retail Stores. It offers a diverse selection of goods, including traditional Chinese medicine, nutritional supplements, skincare, personal care items, and other healthcare solutions, sold under both its proprietary labels and third-party brands. Sales channels encompass wholesale distribution to major chain retailers, independent stores, and traders, alongside direct-to-consumer sales through its own network of brick-and-mortar shops and digital platforms. Founded in 2015, the firm is based in Shatin, Hong Kong.
Key people
Ka Chun Wong
Executive Chairman of the Board, Chief Executive Officer · since 2018
Yuk Chuen Cheung
Company Secretary · since 2020
Ran Cao
Non-Executive Director · since 2025
Yang Hu
Non-Executive Director · since 2024
Ka On Lau
Non-Executive Director · since 2021
Ka Wa Li
Non-Executive Director · since 2019
Yan Liang
Non-Executive Director · since 2024
Kwan Ho Ng
Non-Executive Director · since 2025
Qingqi Yao
Non-Executive Director · since 2019
Ka Lai Chan
Non-Executive Independent Director · since 2020
Siu Wah Chung
Non-Executive Independent Director · since 2020
Chung Hong Mak
Non-Executive Independent Director · since 2021
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||